Skip to content

Nello Mainolfi, Chief Executive Officer at Kymera Therapeutics, sold KYMR on Oct 1, 2026

Data as of Oct 16

▼ SELL$552K4,876 shares at $113.24Nello Mainolfi Chief Executive OfficerKYMR Kymera Therapeutics, Inc.
Watch KYMR
Traded
Oct 1, 2026
Disclosed
Oct 1, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Nello Mainolfi, Chief Executive Officer at Kymera Therapeutics, sold KYMR on Oct 1, 2026TRADEDDISCLOSED
KYMRSimilar stocks (XLV — its sector index fund), rebased to KYMR's price on the disclosure day
KYMR since disclosure
−4.8%
after the sale
Similar stocks (XLV) since disclosure
+6.3%
XLV — its sector index fund

Change in closing price from Oct 1, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLNello Mainolfi Chief Executive OfficerKYMR Kymera Therapeutics, Inc.$950Kdisclosed Oct 1 · filed the same day
  2. ▼ SELLNello Mainolfi Chief Executive OfficerKYMR Kymera Therapeutics, Inc.$30.4Kdisclosed Oct 1 · filed the same day
  3. ▼ SELLNello Mainolfi Chief Executive OfficerKYMR Kymera Therapeutics, Inc.$870Kdisclosed Oct 1 · filed the same day
  4. ▼ SELLNello Mainolfi Chief Executive OfficerKYMR Kymera Therapeutics, Inc.$393Kdisclosed Oct 1 · filed the same day
  5. ▼ SELLNello Mainolfi Chief Executive OfficerKYMR Kymera Therapeutics, Inc.$619Kdisclosed Oct 1 · filed the same day

See every trade on KYMR →